Titan Company Limited Buy Titan Company Limited @3168-3172; Target 3209.0...
Margin recovers; sales yet to pick up Work-in-progress for greenfield project at Kakinada *...
Divis Laboratories (DIVLAB) Ltd Buy Divis Laboratories (DIVLAB) Ltd @3718-3722; ...
Indian pharmaceutical company Divi's Laboratories reported a 49.2% fall in quarterly profit, ...
Domestic equities held on to their positive stance despite mixed global cues. Nifty opened higher...
SAIL Buy Sail Ltd @91.00-91.40; Target 93.00; Stop Loss 90.50 ...
Divis Laboratories Ltd Buy Divis Laboratories Ltd @3532-3536; Target&n...
Beat on revenues, below-par margins but worst seems to be over… About the sto...
Divis Laboratories Ltd Buy Divis Laboratories Ltd @3538-3542 CMP 3542....
State Bank of India Ltd Buy State Bank of India Ltd CMP 526.75; Initiation Range 525.50-526.50...
Work-in-progress for a better outlook We recently met Divis Laboratories (DIVI) management to ...
DIVISLAB Laboratories Ltd * DIVISLAB has been trading in a downward channel since April 2...
Key News SBI Q3 result: Net profit soars 69% YoY to Rs 14,205 crore, beats estimates: Stat...
BENGALURU - Indian pharmaceutical firm Divi's Laboratories Ltd on Friday reported a thir...
Divis Laboratories is the leading manufacturer of APIs (Active pharmaceuticals ingredients), Inte...
Miss in 2QFY23; Growth factors to face softness over medium term No visibility yet to the star...
Margin dips on fall in revenue Divi’s Laboratories’ (Divi’s) Q2FY23 performa...
Below is perspective on Divi`s Laboratories Ltd Quarterly Result by Mr Anmol Das, ...
Near term inflationary pressure; betting on new opportunities in pipeline… Ab...
Short-term hiccups in margin; outlook remains intact * DIVI delivered an in-line earnings in 1...
Religare Super Idea** To Read Complete Report & Disclaimer Click Here ...
Divis Laboratories Ltd Buy Divis Laboratories Ltd @ 3582.00-3587.00 CMP 3582.90&...
The company reported standalone net profit of Rs 882.96 crore for the quarter ended March 31, 202...
Divi's Laboratories Buy Divi's Laboratories @ 4500.00-4504.00 ...
Religare Super Idea To Read Complete Report & Disclaimer Click Here ...
Stock Picks Divi's Laboratories Buy Divi's Laboratories Ltd @ 4...
Custom Synthesis drives earnings Promising outlook, with superior execution, bodes well for co...
Divi's Laboratories is currently trading at Rs. 4334.10, up by 20.70 points or 0.48% from its...
Custom synthesis drive numbers; generics muted… About the stock: Divi’s is engage...
Divi's Laboratories Buy Divi's Laboratories Ltd @ 4798.00-4802.00&n...
BENGALURU - Shares of India's Divi's Laboratories Ltd, which makes the main ingredie...
Margins surprised positively Divi’s Laboratories (Divis) reported Q1FY22 performance bro...
Strong Q1 on all fronts… About the stock: Divi’s is engaged in manufacturing of g...
Building ‘growth engines’ for sustainable earnings momentum DIVI, an Indian P...
Yet another consistent quarter despite industry headwinds Building ‘growth engines&rsquo...
Six cylinder growth engine * DIVI is a strong player in Generic APIs, with a market leading po...
Key News SAIL returns to black; posts Rs 3,897-cr net profit for June quarter Domestic stee...
Strong growth outlook backed by execution… Q4 revenues grew 28.7% YoY to | 1788 crore (...
Strong performance continues Divi’s Laboratories (Divis) reported Q4FY21 performance mar...
On a stellar growth trajectory Multiple levers across Custom Synthesis/API/Nutraceuticals spac...
Key News Divi's Labs Q4 net profit jumps 29% at Rs 502 crore on robust sales Drug firm ...
PRINCE PIPES AND FITTINGS LTD * Stock has given a bullish pennant breakout on daily chart whic...
Divis Laboratories Buy Divis Laboratories Ltd @ 3917.00-3923.00. CMP&n...
Divis Laboratories Buy Divis Laboratories Ltd @ 3754.00-3760.00 CMP 3767.55...
Titan Buy Titan Ltd @ 1528.00-1533.00 CMP 1537.45 TGT 1560.00 SL ...
WIP in niche areas for sustained growth momentum * Divi’s Labs (DIVI), in addition to h...